141 related articles for article (PubMed ID: 20961373)
1. Increasing time delay from presentation until surgical referral for hepatobiliary malignancies.
Croome KP; Chudzinski R; Hanto DW
HPB (Oxford); 2010 Nov; 12(9):644-8. PubMed ID: 20961373
[TBL] [Abstract][Full Text] [Related]
2. Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies.
Schneider EB; Hyder O; Wolfgang CL; Hirose K; Choti MA; Makary MA; Herman JM; Cameron JL; Pawlik TM
J Am Coll Surg; 2012 Nov; 215(5):607-15. PubMed ID: 22921328
[TBL] [Abstract][Full Text] [Related]
3. [Liver, Pancreas, Biliary Tract Cancer Current Issues of Surgical Margin, R0 and R1, in Surgical Resection for Hepatobiliary Pancreatic Cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1415-1416. PubMed ID: 30382035
[No Abstract] [Full Text] [Related]
4. A critical appraisal of laparoscopic staging in hepatobiliary and pancreatic malignancy.
Potter MW; Shah SA; McEnaney P; Chari RS; Callery MP
Surg Oncol; 2000 Nov; 9(3):103-10. PubMed ID: 11356338
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic pathway for solid pancreatic neoplasms: are we applying too many tests?
Driedger MR; Dixon E; Mohamed R; Sutherland FR; Bathe OF; Ball CG
J Surg Res; 2015 Nov; 199(1):39-43. PubMed ID: 25953217
[TBL] [Abstract][Full Text] [Related]
6. Predictors for Surgical Referral in Patients With Pancreatic Cystic Lesions Undergoing Endoscopic Ultrasound: Results From a Large Multicenter Cohort Study.
Ge PS; Gaddam S; Keach JW; Mullady D; Fukami N; Edmundowicz SA; Azar RR; Shah RJ; Murad FM; Kushnir VM; Ghassemi KF; Sedarat A; Watson RR; Amateau SK; Brauer BC; Yen RD; Hosford L; Hollander T; Donahue TR; Schulick RD; Edil BH; McCarter MD; Gajdos C; Attwell AR; Muthusamy VR; Early DS; Wani S
Pancreas; 2016 Jan; 45(1):51-7. PubMed ID: 26262589
[TBL] [Abstract][Full Text] [Related]
7. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
[TBL] [Abstract][Full Text] [Related]
8. Imaging of malignancies of the biliary tract- an update.
Hennedige TP; Neo WT; Venkatesh SK
Cancer Imaging; 2014 Apr; 14(1):14. PubMed ID: 25608662
[TBL] [Abstract][Full Text] [Related]
9. A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery.
Mann CD; Palser T; Briggs CD; Cameron I; Rees M; Buckles J; Berry DP
HPB (Oxford); 2010 Aug; 12(6):380-8. PubMed ID: 20662788
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract][Full Text] [Related]
11. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
12. Reinterpretation of radiological imaging in patients referred to a tertiary referral centre with a suspected pancreatic or hepatobiliary malignancy: impact on treatment strategy.
Tilleman EH; Phoa SS; Van Delden OM; Rauws EA; van Gulik TM; Laméris JS; Gouma DJ
Eur Radiol; 2003 May; 13(5):1095-9. PubMed ID: 12695833
[TBL] [Abstract][Full Text] [Related]
13. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
Miller G; Schwartz LH; D'Angelica M
Surg Oncol Clin N Am; 2007 Apr; 16(2):343-68. PubMed ID: 17560517
[TBL] [Abstract][Full Text] [Related]
14. Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy.
Hu QL; Liu JB; Ellis RJ; Liu JY; Yang AD; D'Angelica MI; Ko CY; Merkow RP
HPB (Oxford); 2020 Feb; 22(2):249-257. PubMed ID: 31350104
[TBL] [Abstract][Full Text] [Related]
15. Management of primary hepatopancreatobiliary small cell carcinoma.
Groeschl RT; Christians KK; Turaga KK; Gamblin TC
J Surg Oncol; 2013 Jun; 107(7):692-5. PubMed ID: 23280574
[TBL] [Abstract][Full Text] [Related]
16. Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy.
Borbath I; Van Beers BE; Lonneux M; Schoonbroodt D; Geubel A; Gigot JF; Deprez PH
Pancreatology; 2005; 5(6):553-61. PubMed ID: 16113592
[TBL] [Abstract][Full Text] [Related]
17. Improving outcomes in senior patients with HPB malignancies: Editorial.
de Liguori Carino N
Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):491. PubMed ID: 33446351
[No Abstract] [Full Text] [Related]
18. Combined pancreas and liver therapies: resection and ablation in hepato-pancreatico-biliary malignancies.
Edwards J; Scoggins C; McMasters K; Martin R
J Surg Oncol; 2013 Jun; 107(7):709-12. PubMed ID: 23335109
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary cystadenomas and cystadenocarcinomas: a report of 33 cases.
Sang X; Sun Y; Mao Y; Yang Z; Lu X; Yang H; Xu H; Zhong S; Huang J
Liver Int; 2011 Oct; 31(9):1337-44. PubMed ID: 21745301
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B
World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
